Shaila J Merchant1, Joseph Kim2, Audrey H Choi3, Virginia Sun4, Joseph Chao5, Rebecca Nelson6. 1. Division of Surgical Oncology, Queen's University, Kingston, ON, Canada. 2. Division of Surgical Oncology, Stony Brook Medicine, Stony Brook, NY, USA. 3. Divisions of Surgical Oncology, City of Hope, Duarte, CA, USA. 4. Nursing Research and Education, City of Hope, Duarte, CA, USA. 5. Medical Oncology, City of Hope, Duarte, CA, USA. 6. Department of Biostatistics, City of Hope, 1500 East Duarte Rd, Duarte, CA, 91010, USA. rnelson@coh.org.
Abstract
BACKGROUND: Although the incidence of gastric cancer has been decreasing, recent reports suggest an increased rate in select populations. We sought to evaluate trends in gastric cancer incidence to identify high-risk populations. METHODS: Gastric cancer incidence rates from 1992 to 2011 were computed with use of the Surveillance, Epidemiology, and End Results (SEER) registry. We evaluated trends in incidence rates by calculating the annual percent change (APC) across three age groups (20-49 years, 50-64 years, and 65 years or older) and four racial/ethnic groups (Hispanics, non-Hispanic whites, blacks, and Asian/Pacific Islanders). RESULTS: We identified 41,428 patients with gastric cancer. For the entire cohort during the study period, the APC was decreased. When patients were grouped according to sex, the APC was flat or decreased in women regardless of age or race/ethnicity. The APC was also flat or decreased for all men except young Hispanic men (20-49 years), who had an increased APC of nearly 1.6 % (1.55 %, 95 % confidence interval 0.26-2.86 %). Furthermore, young Hispanic men were the only group to have increased incidence of stage IV disease (APC 4.34 %, 95 % confidence interval 2.76-5.94 %) and poorly differentiated tumors (APC 2.08 %, 95 % confidence interval 0.48-3.70 %). CONCLUSIONS: The APC of the incidence of gastric cancer in young Hispanic men places it among the top cancers with rising incidence in the USA. This is concomitant with increased incidence of advanced disease at presentation. This major public health concern warrants additional research to determine the cause of the increasing incidence in this group.
BACKGROUND: Although the incidence of gastric cancer has been decreasing, recent reports suggest an increased rate in select populations. We sought to evaluate trends in gastric cancer incidence to identify high-risk populations. METHODS:Gastric cancer incidence rates from 1992 to 2011 were computed with use of the Surveillance, Epidemiology, and End Results (SEER) registry. We evaluated trends in incidence rates by calculating the annual percent change (APC) across three age groups (20-49 years, 50-64 years, and 65 years or older) and four racial/ethnic groups (Hispanics, non-Hispanic whites, blacks, and Asian/Pacific Islanders). RESULTS: We identified 41,428 patients with gastric cancer. For the entire cohort during the study period, the APC was decreased. When patients were grouped according to sex, the APC was flat or decreased in women regardless of age or race/ethnicity. The APC was also flat or decreased for all men except young Hispanic men (20-49 years), who had an increased APC of nearly 1.6 % (1.55 %, 95 % confidence interval 0.26-2.86 %). Furthermore, young Hispanic men were the only group to have increased incidence of stage IV disease (APC 4.34 %, 95 % confidence interval 2.76-5.94 %) and poorly differentiated tumors (APC 2.08 %, 95 % confidence interval 0.48-3.70 %). CONCLUSIONS: The APC of the incidence of gastric cancer in young Hispanic men places it among the top cancers with rising incidence in the USA. This is concomitant with increased incidence of advanced disease at presentation. This major public health concern warrants additional research to determine the cause of the increasing incidence in this group.
Authors: T E Buffart; B Carvalho; E Hopmans; V Brehm; E Klein Kranenbarg; T B M Schaaij-Visser; P P Eijk; N C T van Grieken; B Ylstra; C J H van de Velde; G A Meijer Journal: J Pathol Date: 2007-01 Impact factor: 7.996
Authors: James C Yao; Jennifer F Tseng; Samidha Worah; Kenneth R Hess; Paul F Mansfield; Christopher H Crane; Isac I Schnirer; Satish Reddy; Silvia S Chiang; Azmeena Najam; Christina Yu; Geoffrey G Giacco; Keping Xie; Tsung-Teh Wu; Barry W Feig; Peter W T Pisters; Jaffer A Ajani Journal: J Clin Oncol Date: 2005-05-01 Impact factor: 44.544
Authors: Rebecca L Siegel; Stacey A Fedewa; Kimberly D Miller; Ann Goding-Sauer; Paulo S Pinheiro; Dinorah Martinez-Tyson; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-09-16 Impact factor: 508.702
Authors: Claus Wilhelm Schildberg; Mohammed Abba; Susanne Merkel; Abbas Agaimy; Arno Dimmler; Anne Schlabrakowski; Roland Croner; Jörg Hendrik Leupold; Werner Hohenberger; Heike Allgayer Journal: Adv Med Sci Date: 2014-03-28 Impact factor: 3.287
Authors: Eric M Groh; Noorie Hyun; David Check; Theo Heller; R Taylor Ripley; Jonathan M Hernandez; Barry I Graubard; Jeremy L Davis Journal: J Gastrointest Surg Date: 2018-12-03 Impact factor: 3.452
Authors: Ibrahim Nassour; Hannah Fullington; Linda S Hynan; Adam C Yopp; Mathew M Augustine; Patricio M Polanco; Michael A Choti; John C Mansour; Sam C Wang; Matthew R Porembka Journal: Ann Surg Oncol Date: 2017-02-13 Impact factor: 5.344
Authors: Shailja C Shah; Qi Dai; Xiangzhu Zhu; Richard M Peek; Walter Smalley; Christianne Roumie; Martha J Shrubsole Journal: Int J Cancer Date: 2019-10-12 Impact factor: 7.396
Authors: Steven M Zamora; Paulo S Pinheiro; Scarlett Lin Gomez; Katherine G Hastings; Latha P Palaniappan; Jiaqi Hu; Caroline A Thompson Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-05-30 Impact factor: 4.254
Authors: Zhensheng Wang; David Y Graham; Anam Khan; Maya Balakrishnan; Hannah R Abrams; Hashem B El-Serag; Aaron P Thrift Journal: Int J Epidemiol Date: 2018-06-01 Impact factor: 7.196